-
For PAH Treatment, Extended-Release Ralinepag Shows Positive Phase 1 Results
Extended-release ralinepag, a treatment candidate for pulmonary arterial hypertension, showed benefits over immediate-release medications in Phase 1 trials.
Click here to read more about this story.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.